Stockreport

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the company will host a Multiple Sclerosis (MS) Research and Development (R&D) [Read more]